tiprankstipranks
Advertisement
Advertisement
Harmony Biosciences reports Q4 adjusted EPS 57c, consensus $1.07
PremiumThe FlyHarmony Biosciences reports Q4 adjusted EPS 57c, consensus $1.07
1M ago
Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.01B
Premium
The Fly
Harmony Biosciences backs FY26 revenue view $1B-$1.04B, consensus $1.01B
1M ago
Harmony Biosciences downgraded to Hold from Buy at Deutsche Bank
Premium
The Fly
Harmony Biosciences downgraded to Hold from Buy at Deutsche Bank
1M ago
Harmony Biosciences: Wakix Outperformance and Milestone-Rich Pipeline Underpin Buy Rating and Favorable Risk-Reward
PremiumRatingsHarmony Biosciences: Wakix Outperformance and Milestone-Rich Pipeline Underpin Buy Rating and Favorable Risk-Reward
3M ago
Harmony Biosciences price target lowered to $45 from $48 at Truist
Premium
The Fly
Harmony Biosciences price target lowered to $45 from $48 at Truist
3M ago
Harmony Biosciences partners with Beacon Biosignals for EEG in hypersomnia
Premium
The Fly
Harmony Biosciences partners with Beacon Biosignals for EEG in hypersomnia
4M ago
Promising Developments and Upcoming Catalysts Drive Buy Rating for Harmony Biosciences
PremiumRatingsPromising Developments and Upcoming Catalysts Drive Buy Rating for Harmony Biosciences
4M ago
Harmony Biosciences announces results from pitolisant bioequivalence study
Premium
The Fly
Harmony Biosciences announces results from pitolisant bioequivalence study
4M ago
Harmony Biosciences doses first patient in BP1.15205 trial
Premium
The Fly
Harmony Biosciences doses first patient in BP1.15205 trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100